Simon Joel

2.6k total citations
36 papers, 1.7k citations indexed

About

Simon Joel is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Simon Joel has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Simon Joel's work include Pain Management and Opioid Use (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer therapeutics and mechanisms (4 papers). Simon Joel is often cited by papers focused on Pain Management and Opioid Use (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer therapeutics and mechanisms (4 papers). Simon Joel collaborates with scholars based in United Kingdom, Netherlands and Italy. Simon Joel's co-authors include M L Slevin, Richard H. Osborne, Pedro Casado, Bart Vanhaesebroeck, Juan‐Carlos Rodríguez‐Prados, Pedro R. Cutillas, Sylvie M. Guichard, Sabina Cosulich, Thomas Powles and John G. Gribben and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Simon Joel

36 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Joel United Kingdom 19 652 359 273 250 235 36 1.7k
Kevin J. Petty United States 20 511 0.8× 121 0.3× 117 0.4× 122 0.5× 249 1.1× 37 1.5k
S. Leigh Verbois United States 8 406 0.6× 248 0.7× 114 0.4× 57 0.2× 64 0.3× 9 1.1k
Peter Zannikos United States 19 215 0.3× 204 0.6× 71 0.3× 114 0.5× 59 0.3× 57 1.0k
Ernst‐Ulrich Griese Germany 19 334 0.5× 472 1.3× 51 0.2× 259 1.0× 411 1.7× 29 1.6k
Ken‐ichi Fujita Japan 20 784 1.2× 420 1.2× 30 0.1× 71 0.3× 64 0.3× 53 1.9k
Bimal Malhotra United States 20 162 0.2× 198 0.6× 68 0.2× 144 0.6× 158 0.7× 69 1.5k
Yijing He China 27 724 1.1× 798 2.2× 24 0.1× 617 2.5× 119 0.5× 138 2.9k
Gordon Loewen United States 13 381 0.6× 140 0.4× 52 0.2× 55 0.2× 101 0.4× 38 861
Keiko Maekawa Japan 31 1.3k 2.0× 665 1.9× 15 0.1× 189 0.8× 529 2.3× 98 2.8k
Michel Lemaire Japan 28 619 0.9× 952 2.7× 14 0.1× 699 2.8× 107 0.5× 62 2.4k

Countries citing papers authored by Simon Joel

Since Specialization
Citations

This map shows the geographic impact of Simon Joel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Joel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Joel more than expected).

Fields of papers citing papers by Simon Joel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Joel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Joel. The network helps show where Simon Joel may publish in the future.

Co-authorship network of co-authors of Simon Joel

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Joel. A scholar is included among the top collaborators of Simon Joel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Joel. Simon Joel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghazaly, Essam, Paul A. Smith, Bryan D. Young, et al.. (2014). SKIP Is Underexpressed in AML Leading to Sphingosine Kinase Hypofunction. Blood. 124(21). 5324–5324. 1 indexed citations
2.
3.
Gretton, Sophy, Joy Ross, Hiroe Sato, et al.. (2012). Plasma Morphine and Metabolite Concentrations Are Associated With Clinical Effects of Morphine in Cancer Patients. Journal of Pain and Symptom Management. 45(4). 670–680. 26 indexed citations
4.
Stevens, Jane, Rachel Waters, Shireen Kassam, et al.. (2011). Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies. British Journal of Haematology. 154(4). 448–456. 17 indexed citations
5.
6.
Ghazaly, Essam, et al.. (2010). A Synergistic Interaction between Lapatinib and Chemotherapy Agents in a Panel of Cell Lines Is Due to the Inhibition of the Efflux Pump BCRP. Molecular Cancer Therapeutics. 9(12). 3322–3329. 32 indexed citations
7.
Streetly, Matthew, Lenushka Maharaj, Simon Joel, et al.. (2010). GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death. Blood. 115(19). 3939–3948. 102 indexed citations
8.
Pearce, Daniel J., Robert W. Wilkinson, Claire Crafter, et al.. (2009). AZD1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo. Cancer Research. 69(10). 4150–4158. 62 indexed citations
9.
Popat, Rakesh, Heather Oakervee, Catherine Williams, et al.. (2009). Bortezomib, low‐dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma. British Journal of Haematology. 144(6). 887–894. 37 indexed citations
10.
Powles, Thomas, Jonathan Shamash, Elodie Noël, et al.. (2009). The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines. Cancer Chemotherapy and Pharmacology. 64(5). 925–933. 10 indexed citations
11.
Liu, Wai M., Katherine A. Scott, Jonathan Shamash, Simon Joel, & Thomas Powles. (2008). Enhancing thein vitrocytotoxic activity of Δ9-tetrahydrocannabinol in leukemic cells through a combinatorial approach. Leukemia & lymphoma. 49(9). 1800–1809. 42 indexed citations
12.
Joel, Simon, et al.. (2007). The plasma and intracellular pharmacokinetics of clofarabine in pediatric leukemia patients. Cancer Research. 67. 1566–1566. 2 indexed citations
13.
Popat, Rakesh, Simon Joel, Heather Oakervee, & Jamie Cavenagh. (2006). Bortezomib for multiple myeloma. Expert Opinion on Pharmacotherapy. 7(10). 1337–1346. 11 indexed citations
14.
Liu, Wai M., Thomas Powles, Jonathan Shamash, et al.. (2003). Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity. Oncogene. 23(4). 981–990. 41 indexed citations
15.
16.
Hunt, Anne, Simon Joel, G. Dick, & Ann Goldman. (1999). Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain. The Journal of Pediatrics. 135(1). 47–55. 54 indexed citations
17.
Joel, Simon. (1996). The clinical pharmacology of etoposide: an update. Cancer Treatment Reviews. 22(3). 179–221. 41 indexed citations
18.
Joel, Simon. (1995). The comparative clinical pharmacology of vincristine and vindesine: Does vindesine offer any advantage in clinical use?. Cancer Treatment Reviews. 21(6). 513–525. 19 indexed citations
19.
Osborne, Richard H., et al.. (1993). The pharmacokinetics of morphine and morphine glucuronides in kidney failure. Clinical Pharmacology & Therapeutics. 54(2). 158–167. 131 indexed citations
20.
Osborne, Richard H., et al.. (1990). Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine-6-glucuronide. Clinical Pharmacology & Therapeutics. 47(1). 12–19. 343 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin J. Petty Breakdown of academic impact, for papers by S. Leigh Verbois Breakdown of academic impact, for papers by Peter Zannikos Breakdown of academic impact, for papers by Ernst‐Ulrich Griese Breakdown of academic impact, for papers by Ken‐ichi Fujita Breakdown of academic impact, for papers by Bimal Malhotra Breakdown of academic impact, for papers by Yijing He Breakdown of academic impact, for papers by Gordon Loewen Breakdown of academic impact, for papers by Keiko Maekawa Breakdown of academic impact, for papers by Michel Lemaire
Rankless by CCL
2026